Re‐Analysis of the STEADY‐PD II Trial—Evidence for Slowing the Progression of Parkinson's Disease
出版年份 2021 全文链接
标题
Re‐Analysis of the
STEADY‐PD II
Trial—Evidence for Slowing the Progression of Parkinson's Disease
作者
关键词
-
出版物
MOVEMENT DISORDERS
Volume 37, Issue 2, Pages 334-342
出版商
Wiley
发表日期
2021-11-12
DOI
10.1002/mds.28850
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Isradipine plasma pharmacokinetics and exposure–response in early Parkinson’s disease
- (2021) Charles S. Venuto et al. Annals of Clinical and Translational Neurology
- Calcium Channel blockers are associated with reduced risk of Parkinson's disease in patients with hypertension: A population-based retrospective cohort study
- (2021) Yuan-Fu Tseng et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Scientists rise up against statistical significance
- (2019) Valentin Amrhein et al. NATURE
- Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain
- (2019) Steven M. Graves et al. NATURE NEUROSCIENCE
- Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease
- (2017) D. James Surmeier et al. EXPERIMENTAL NEUROLOGY
- Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
- (2017) J.A. Obeso et al. MOVEMENT DISORDERS
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- A review of disease progression models of Parkinson's disease and applications in clinical trials
- (2016) Charles S. Venuto et al. MOVEMENT DISORDERS
- Predictors of time to initiation of symptomatic therapy in early Parkinson's disease
- (2016) Tanya Simuni et al. Annals of Clinical and Translational Neurology
- Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study
- (2014) Bolaji E Egbewale et al. BMC Medical Research Methodology
- Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD)
- (2013) MOVEMENT DISORDERS
- Interpreting the results of Parkinson's disease clinical trials: Time for a change
- (2011) Nick H. G. Holford et al. MOVEMENT DISORDERS
- Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts
- (2011) Connie Marras et al. MOVEMENT DISORDERS
- Measuring continuous baseline covariate imbalances in clinical trial data
- (2011) Jody D Ciolino et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started